Metastatic Leiomyosarcoma Biomarker Protocol

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 22, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Leiomyosarcoma
Interventions
OTHER

Plasma Collection

Patients will provide tissue and blood samples. No medical intervention will be completed for study purposes

Trial Locations (10)

2050

RECRUITING

Chris O'Brien Lifehouse, Camperdown

3000

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

43210

RECRUITING

Ohio State University, Columbus

48109

RECRUITING

University of Michigan Cancer Center, Ann Arbor

55901

RECRUITING

Mayo Clinic, Rochester

77030

RECRUITING

MD Anderson, Houston

90403

RECRUITING

Sarcoma Oncology Research Center, Santa Monica

02215

RECRUITING

Dana- Farber, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER